Paratek Pharmaceuticals Announces Stockholder Approval of Acquisition by Gurnet Point Capital and Novo Holdings A/S
BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (“Paratek”) (Nasdaq: PRTK), a commercial-stage…
BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (“Paratek”) (Nasdaq: PRTK), a commercial-stage…
SEATTLE, Sept. 18, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company…
An Independent Data and Safety Monitoring Board (DSMB) Recently Evaluated the Interim Patient Safety Database…
Expanded network coverage and new retail store in Soldotna will better serve Kenai Peninsula residents…
New CrowdStrike Marketplace delivers one-stop shop to reduce risk and cybersecurity stack complexity on the…
LONDON, Sept. 18, 2023 (GLOBE NEWSWIRE) — With Apple rolling out its latest operating system,…
SAN FRANCISCO, Sept. 18, 2023 (GLOBE NEWSWIRE) — Motorq, the leading connected vehicle analytics and…
Toronto, Ontario–(Newsfile Corp. – September 18, 2023) – Amidst the ever-evolving financial landscape, The Technical…
Cape Town, South Africa, Sept 18, 2023 – (ACN Newswire) – Ennova Holdings, a forward-thinking…
BARCELONA, SPAIN, Sept 18, 2023 – (ACN Newswire) – Scytl, leader in online voting and…
Vancouver, British Columbia–(ACN Newswire – September 18, 2023) – Doubleview Gold Corp. (TSXV: DBG) (OTCQB:…
Top global sugar producer projects up to $5 million benefit using C3 Generative AI REDWOOD…
BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) — LAPIX Therapeutics, Inc. (“LAPIX”), a biopharmaceutical company focused…
BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) — LAPIX Therapeutics, Inc. (“LAPIX”), a biopharmaceutical company focused…
Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI)…
Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI)…
AI-powered target discovery for a bacterial pathogen with a high medical need where no vaccine…
AI-powered target discovery for a bacterial pathogen with a high medical need where no vaccine…
CORAL GABLES, Fla., Sept. 18, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX),…
CORAL GABLES, Fla., Sept. 18, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX),…